» Articles » PMID: 38821437

Risk Factors for Acute Asthma Exacerbations in Adults With Mild Asthma

Overview
Date 2024 May 31
PMID 38821437
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although individuals with mild asthma account for 30% to 40% of acute asthma exacerbations (AAEs), relatively little attention has been paid to risk factors for AAEs in this population.

Objective: To identify risk factors associated with AAEs in patients with mild asthma.

Methods: This was a retrospective cohort study. We used administrative data from a large managed care organization to identify 199,010 adults aged 18 to 85 years who met study criteria for mild asthma between 2013 and 2018. An asthma-coded qualifying visit (index visit) was identified for each patient. We then used information at the index visit or from the year before the index visit to measure potential risk factors for AAEs in the subsequent year. An AAE was defined as either an asthma-coded hospitalization or emergency department visit, or an asthma-related systemic corticosteroid administration (intramuscular or intravenous) or oral corticosteroid dispensing. Poisson regression models with robust SEs were used to estimate the adjusted risk ratios for future AAEs.

Results: In the study cohort, mean age was 44 years and 64% were female; 6.5% had AAEs within 1 year after the index visit. In multivariate models, age, sex, race, ethnicity, smoking status, body mass index, prior acute asthma care, and a variety of comorbidities and other clinical characteristics were significant predictors for future AAE risk.

Conclusion: Population-based disease management strategies for asthma should be expanded to include people with mild asthma in addition to those with moderate to severe disease.

Citing Articles

Global, regional and national burden of asthma attributable to NO from 1990 to 2021: an analysis from the Global Burden of Disease Study 2021.

Li J, Zhang C, Qin E, Sun J, Liu L, Pu G BMJ Open. 2025; 15(2):e095210.

PMID: 39915028 PMC: 11800289. DOI: 10.1136/bmjopen-2024-095210.


Neighborhood Deprivation and Crime on Asthma Exacerbations and Utilization in Mild Adult Asthma.

Xu S, Puttock E, Zeiger R, Vollmer W, Schatz M, Crawford W J Allergy Clin Immunol Pract. 2024; 12(11):2966-2974.e11.

PMID: 39147276 PMC: 11560689. DOI: 10.1016/j.jaip.2024.08.014.

References
1.
Guarnieri G, Batani V, Senna G, Dama A, Vianello A, Caminati M . Is mild asthma truly mild? The patients' real-life setting. Expert Rev Respir Med. 2023; 16(11-12):1263-1272. DOI: 10.1080/17476348.2023.2167714. View

2.
Fuhlbrigge A, Kitch B, Paltiel A, Kuntz K, Neumann P, Dockery D . FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001; 107(1):61-7. DOI: 10.1067/mai.2001.111590. View

3.
Brown E, Sayed N, Van Enkevort E, Kulikova A, Nakamura A, Khan D . A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder. J Allergy Clin Immunol Pract. 2018; 6(5):1604-1612. PMC: 6107441. DOI: 10.1016/j.jaip.2018.01.010. View

4.
Murray C, Simpson A, Custovic A . Allergens, viruses, and asthma exacerbations. Proc Am Thorac Soc. 2005; 1(2):99-104. DOI: 10.1513/pats.2306027. View

5.
Golam S, Janson C, Beasley R, FitzGerald J, Harrison T, Chipps B . The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study. Respir Med. 2022; 200:106863. DOI: 10.1016/j.rmed.2022.106863. View